Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PGR | hg38_v1_chr11_-_101129806_101129822 | 0.06 | 8.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_+_101452629 Show fit | 1.78 |
ENST00000622834.4
ENST00000545560.6 ENST00000376180.8 |
integrin subunit beta like 1 |
|
chr13_+_101452569 Show fit | 0.99 |
ENST00000618057.4
|
integrin subunit beta like 1 |
|
chr3_-_114624921 Show fit | 0.78 |
ENST00000393785.6
|
zinc finger and BTB domain containing 20 |
|
chr8_-_107497909 Show fit | 0.76 |
ENST00000517746.6
|
angiopoietin 1 |
|
chr5_+_93583212 Show fit | 0.72 |
ENST00000327111.8
|
nuclear receptor subfamily 2 group F member 1 |
|
chr3_-_114624979 Show fit | 0.68 |
ENST00000676079.1
|
zinc finger and BTB domain containing 20 |
|
chrX_+_16946862 Show fit | 0.65 |
ENST00000303843.7
|
RALBP1 associated Eps domain containing 2 |
|
chr10_+_68106109 Show fit | 0.60 |
ENST00000540630.5
ENST00000354393.6 |
myopalladin |
|
chr2_-_189179754 Show fit | 0.54 |
ENST00000374866.9
ENST00000618828.1 |
collagen type V alpha 2 chain |
|
chr12_+_78863962 Show fit | 0.44 |
ENST00000393240.7
|
synaptotagmin 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.9 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.3 | 0.8 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.3 | 0.8 | GO:0035691 | macrophage migration inhibitory factor signaling pathway(GO:0035691) |
0.0 | 0.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.5 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.0 | 0.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.5 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.3 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 1.1 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 1.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 1.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.8 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |